Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Chiasma stock
Own Chiasma stock in just a few minutes.
Chiasma, Inc is a biotechnology business based in the US. Chiasma shares (CHMA) are listed on the NASDAQ and all prices are listed in US Dollars. Chiasma employs 85 staff and has a trailing 12-month revenue of around USD$1.1 million.
How to buy shares in Chiasma
- Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
- Search for Chiasma. Find the stock by name or ticker symbol: CHMA. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Chiasma reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Chiasma, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Chiasma. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Chiasma share price
Use our graph to track the performance of CHMA stocks over time.Chiasma shares at a glance
Information last updated 2021-04-08.
| 52-week range | USD$2.77 - USD$7.75 |
|---|---|
| 50-day moving average | USD$3.45 |
| 200-day moving average | USD$4.0089 |
| Wall St. target price | USD$13.6 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | USD$-1.227 |
Buy Chiasma shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Chiasma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Chiasma financials
| Revenue TTM | USD$1.1 million |
|---|---|
| Gross profit TTM | USD$1 million |
| Return on assets TTM | -32.09% |
| Return on equity TTM | -84.23% |
| Profit margin | 0% |
| Book value | $1.588 |
| Market capitalisation | USD$175.6 million |
TTM: trailing 12 months
Shorting Chiasma shares
There are currently 2.9 million Chiasma shares held short by investors – that's known as Chiasma's "short interest". This figure is 7% up from 2.7 million last month.
There are a few different ways that this level of interest in shorting Chiasma shares can be evaluated.
Chiasma's "short interest ratio" (SIR)
Chiasma's "short interest ratio" (SIR) is the quantity of Chiasma shares currently shorted divided by the average quantity of Chiasma shares traded daily (recently around 1.8 million). Chiasma's SIR currently stands at 1.63. In other words for every 100,000 Chiasma shares traded daily on the market, roughly 1630 shares are currently held short.
However Chiasma's short interest can also be evaluated against the total number of Chiasma shares, or, against the total number of tradable Chiasma shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Chiasma's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Chiasma shares in existence, roughly 50 shares are currently held short) or 0.0564% of the tradable shares (for every 100,000 tradable Chiasma shares, roughly 56 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Chiasma.
Find out more about how you can short Chiasma stock.
Chiasma share dividends
We're not expecting Chiasma to pay a dividend over the next 12 months.
Chiasma share price volatility
Over the last 12 months, Chiasma's shares have ranged in value from as little as $2.77 up to $7.75. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Chiasma's is 1.3806. This would suggest that Chiasma's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Chiasma overview
Chiasma, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing oral medications using transient permeability enhancer technology platform for the treatment of rare and serious chronic disease worldwide. The company offers MYCAPSSA, an oral octreotide capsule for the long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide. It also develops MPOWERED, an oral octreotide capsule, which has completed Phase III clinical trials for the maintenance treatment of adult patients with acromegaly. Chiasma, Inc. was incorporated in 2001 and is headquartered in Needham, Massachusetts.
Frequently asked questions
More guides on Finder
-
How to buy PrimeEnergy Resources Corporation stock
Steps to owning and managing PNRG, with 24-hour and historical pricing before you buy.
-
How to buy Premier stock
Steps to owning and managing PINC, with 24-hour and historical pricing before you buy.
-
How to buy Predictive Oncology stock
Steps to owning and managing POAI, with 24-hour and historical pricing before you buy.
-
How to buy Powerbridge Technologies CoLtd stock
Steps to owning and managing PBTS, with 24-hour and historical pricing before you buy.
-
How to buy Portman Ridge Finance Corporation stock
Steps to owning and managing PTMN, with 24-hour and historical pricing before you buy.
-
How to buy Popular stock
Steps to owning and managing BPOP, with 24-hour and historical pricing before you buy.
-
How to buy Playa Hotels-and-Resorts N-V stock
Steps to owning and managing PLYA, with 24-hour and historical pricing before you buy.
-
How to buy Plains GP Holdings L-P stock
Steps to owning and managing PAGP, with 24-hour and historical pricing before you buy.
-
How to buy Plains All American Pipeline L-P stock
Steps to owning and managing PAA, with 24-hour and historical pricing before you buy.
-
How to buy Property Solutions Acquisition stock
Steps to owning and managing PSACU, with 24-hour and historical pricing before you buy.
Ask an Expert